TALPHERA, INC. — Director's Dealing 2017

Aug 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2017-08-22

Reporting Person: Palmer Pamela P (Director, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-22	Common Stock	P	10000	$2.9487	Acquired	415801	Direct

Footnotes

F1: This is a weighted average purchase price. Shares were purchased in the range of $2.9250 and $2.95.

F2: Balance includes non-reportable acquisition of 6,786 shares of Common Stock through the Company's Employee Stock Purchase Plan.